INTERNATIONAL DIABETES MANAGEMENT PRACTICE STUDY (IDMPS): RESOURCE USE ASSOCIATED WITH TYPE 2 DIABETES IN AFRICA, MIDDLE EAST, SOUTH ASIA, EURASIA AND TURKEY CONCLUSIONS
The IDMPS is an ongoing international, multicentre, observational study, which has been conducted annually for the past six years (one wave per year) in non-Western countries. Objectives of the study included the assessment of the therapeutic management, date of initiation, characteristics and management of insulin therapy and the assessment of the health economic impact of T2DM and its complications. Cross-sectional data from 8,156 patients recruited across four geographical regions (18 countries) was collected as part of the 5th wave of the IDMPS (2011 IDMPS ( -2012 Results of this study demonstrate that in South Asia, Eurasia, Africa, Middle East and Turkey, development of micro and macrovascular complications are key drivers for the economic burden of T2DM.
• Patient demographics and clinical characteristics (Table 1) were comparable across the different regions; The prevalence of micro-and macro-vascular complications was highest in Eurasia with 87% and 47% respectively
• 76% to 94% of patients were on oral antidiabetic drugs (OAD); 23% to 50% were on insulin ( Figure 1) • The mean number of annual hospitalisations due to diabetes varied between 0.3 (Middle East) and 1.7 (Eurasia); most emergency room visits were reported in Turkeymean of 0.9 annually (Figure 2 ) • Microvascular complications were associated with increased risk of hospitalisations in all regions with IRRs (CI 95%) of 3.5 (1.8 -7.0), 3.4 (2.2 -5.1), 3.7 (2.2 -5.1), 1.7 (1.0 -2.9) and 3.4 (2.2 -5.1) respectively. 
